Credit Suisse’s Edwards Lifesciences EW Stock Holding History

Credit Suisse’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,900	Closed	-$1.67M	–	3839
2021 Q4	$1.67M	Sell	12,900 -14,900	-54%	-$1.74M	﹤0.01%	2923
2021 Q3	$3.15M	Hold	27,800	–	–	﹤0.01%	2446
2021 Q2	$2.88M	Hold	27,800	–	–	﹤0.01%	2544
2021 Q1	$2.33M	Buy	27,800 +20,900	+303%	+$1.77M	﹤0.01%	2702
2020 Q4	$629K	Buy	+6,900	New	+$572K	﹤0.01%	3665
2019 Q2	–	Sell	-13,500	Closed	-$861K	–	4144
2019 Q1	$861K	Buy	+13,500	New	+$770K	﹤0.01%	3000

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Credit Suisse's EW Position: Q1 2024 in Review

Credit Suisse increased its Edwards Lifesciences (EW) stake by 2% in Q1 2024, buying an estimated $2.63M and bringing the position to 1,615,396 shares worth $154M. The position accounts for 0.15% of the portfolio, ranked #120.

Credit Suisse first reported a position in EW in Q2 2013 and has held it in 44 quarters since. The position peaked at $202M in Q4 2021. 1,279 funds tracked by Wall St. Rank hold EW as of Q1 2024.

Credit Suisse held 1,615,396 shares of Edwards Lifesciences worth $154M as of Q1 2024.
Credit Suisse bought 31,334 Edwards Lifesciences shares in Q1 2024, an estimated $2.63M.
Edwards Lifesciences made up 0.15% of Credit Suisse's portfolio in Q1 2024, its #120 holding.
Credit Suisse first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 44 quarters since.
Credit Suisse's Edwards Lifesciences position peaked at $202M in Q4 2021.
1,279 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.